Factors predicting resource utilization and survival after major amputation  by Henry, Antonia J. et al.
From the New England Society for Vascular SurgeryFrom
Su
sio
H
This
A
In
Auth
Pres
fo
Rep
&
Bo
The
to
m
0741
Cop
V
http
784Factors predicting resource utilization and survival
after major amputation
Antonia J. Henry, MD, MPH,a,c Nathanael D. Hevelone, MPH,a Alexander T. Hawkins, MD,a,b,c
Michael T. Watkins, MD,b,c Michael Belkin, MD,a,c and Louis L. Nguyen, MD, MBA, MPH,a,c
Boston, Mass
Objective: Major amputation is associated with increased short-term healthcare resource utilization (RU), early mortality,
and socioeconomic status (SES) disparities. Our objective is to study patient-speciﬁc and SES-related predictors of long-
term RU and survival after amputation.
Methods: This retrospective analysis identiﬁed 364 adult patients who underwent index major amputation for critical limb
ischemia from January 1995 through December 2000 at two tertiary centers with outcomes through December 2010.
Age, gender, SES (race, income, insurance, and marital status), comorbidities (congestive heart failure [CHF], diabetes,
diabetes with complications, and renal failure [RF]), subsequent procedures, cumulative length of stay (cLOS), and
mortality were analyzed. Bivariate and multivariate Poisson regression for subsequent procedures and cLOS and Cox
proportional hazard modeling for all-cause mortality were undertaken.
Results: During a mean follow-up of 3.25 years, amputation patients had mean cLOS of 71.2 days per person-year
(median, 17.6), 19.5 readmissions per person-year (median, 2.1), 0.57 amputation-related procedures (median, 0),
and 0.31 cardiovascular procedures (median, 0). Below-knee amputation as the index procedure was performed in 70% of
patients, and 25% had additional amputation procedures. Of readmissions at #30 days, 52% were amputation-related.
Overall mortality during follow-up was 86.9%; 37 patients (10.2%) died within 30 days. Among patients surviving
>30 days, multivariate Poisson regression demonstrated that younger age (incidence rate ratio [IRR], 0.98), public
insurance (IRR, 1.63), CHF (IRR, 1.60), and RF (IRR, 2.12) were associated with increased cLOS. Diabetes with
complications (IRR, 1.90) and RF (IRR, 2.47) affected subsequent amputation procedures. CHF (IRR, 1.83) and RF
(IRR, 3.67) were associated with a greater number of cardiovascular procedures. Cox proportional hazard modeling
indicated older age (hazard ratio [HR], 1.04), CHF (HR, 2.26), and RF (HR, 2.60) were risk factors for decreased
survival. Factors associated with SES were not signiﬁcantly related to the outcomes.
Conclusions: This study found that RU is high for amputees, and increased RU persists beyond the perioperative period.
Results were similar across SES indices, suggesting higher SES may not be protective against poor outcomes when limb
salvage is no longer attainable. These ﬁndings support the hypothesis that SES disparities may be more modiﬁable during
earlier stages of care for critical limb ischemia. (J Vasc Surg 2013;57:784-90.)Major amputation is a marker for atherosclerotic disease
burden and is associated with subsequent resource utiliza-
tion (RU) and mortality.1,2 Among surgeons, amputation
is considered to be the end point of treatment for critical
limb ischemia (CLI). However, vascular surgeons continue
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://dx.doi.org/10.1016/j.jvs.2012.09.035interventions for wound care, conversions to more proximal
amputation levels, treatment of peripheral artery disease
(PAD) in the contralateral limb, and management of
systemic atherosclerosis. Although measures of appropriate
RU in patients undergoing major amputation have yet to
be deﬁned, characterizing the nature of RU and the
patient-speciﬁc and socioeconomic status (SES)-related
predictors of long-term RU and survival after amputation
may identify interventions to improve outcomes for these
patients.
Treatment of PAD consumes signiﬁcant health care
resources. The estimated annual cost of vascular-related
hospitalizations in patients with PAD is $21 billion. These
costs are driven by subsequent surgical interventions and
medical treatment of systemic atherosclerosis.3 An analysis
of 2-year hospitalization costs in patients in the Reduction
of Atherothrombosis for Continued Health (REACH)
study found that patients undergoing open revasculariza-
tion or amputation for CLI were more likely to experience
recurring hospitalizations and repeat revascularization
procedures than patients with claudication who were
treated with percutaneous revascularization.1 Longer-
term RU in patients undergoing major amputation for
CLI or diabetes has not been studied extensively.
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failure, and diabetes were predictors of undergoing
amputation rather than lower extremity revascularization
for CLI.4 These factors continue to have an impact on
subsequent RU and survival in patients undergoing lower
extremity revascularization.1,5,6 A higher burden of comor-
bid disease and fewer socioeconomic resources also may be
associated with increased rates of readmission and reinter-
ventions and decreased survival after amputation.
Undergoing major amputation for CLI is associated
with future RU and premature mortality.7 Not only do
amputees require ongoing vascular care after limb salvage
procedures have been unsuccessful, but this procedure is
a marker of other health care resource needs. Under-
standing the factors related to long-term RU and survival
could identify potential interventions to improve quality
of life for amputees with CLI. The objectives of this retro-
spective study were to characterize long-term RU and
survival in patients undergoing amputation for CLI and
to investigate the impact of comorbidities and lower SES
on outcomes after amputation. We hypothesized that
patients with fewer socioeconomic resources and more
comorbid diseases would have longer cumulative length
of stay (cLOS), more subsequent amputation-related and
cardiovascular procedures, and decreased survival.
METHODS
Study cohort. Data were obtained from the Partners
Research Patient Data Registry. The study cohort included
adult subjects undergoing index major amputation for CLI
at two Partners Health Care Institutions between January
1995 and December 2000. To include subjects who were
likely to return to these institutions for subsequent proce-
dures or readmissions and have clinical information in
institutional databases available for analysis, subjects with
no clinical encounter in the year before the start of data
collection were excluded. The study was approved by the
Partners Human Research Committee.
Independent variables of interest included age at index
amputation, gender, race, median household income for
zip code, marital status, comorbid diseases, and amputation
level. Income was deﬁned as the median household income
for the patient’s residential zip code from the 1999 U.S.
Census. Comorbid diseases present at the time of the
amputation were deﬁned based on International Classiﬁca-
tion of Diseases, 9th Edition, Clinical Modiﬁcation diagnosis
codes present during the admission when the index ampu-
tation was performed by applying an algorithm developed
as part of the Healthcare Cost and Utilization Project,
a federal, state, and industry partnership sponsored by the
Agency for Healthcare Research and Quality.8 The comor-
bidities of interest included congestive heart failure, dia-
betes mellitus, diabetes mellitus with complications, and
renal failure.
The primary outcomes were additional amputation-
related procedures, subsequent cardiovascular procedures,
cLOS, and survival. Additional amputation-related proce-
dures included revisions of prior amputations, conversionsto more proximal amputations, and amputations of the
contralateral limb. Subsequent cardiovascular procedures
included open and endovascular lower extremity revascu-
larization procedures, open and endovascular carotid revas-
cularization procedures, open and endovascular abdominal
aortic aneurysm repair, percutaneous coronary transluminal
angioplasty, and coronary artery bypass grafting. The cLOS
was calculated by counting all days of inpatient admission
to either institution occurring for any diagnosis after
discharge from the admission during which the index
amputation was performed. Date of death was reported
by the Social Security Death Index. If date of death was
missing, the discharge date from the last clinical encounter
was deﬁned as the date of censoring. Person-time under
observation was deﬁned as time from index amputation
to death or censoring.
Statistical methods. Descriptive statistics were calcu-
lated for the means and frequencies of the independent
variables with Wilcoxon rank-sum tests of categorical
variables and Kruskal-Wallis tests for continuous variables
where appropriate. Poisson regression was selected for the
analysis because the distribution of outcomes for cLOS
and postamputation procedures approximated the Poisson
distribution.5 Bivariate and multivariate Poisson regression
for additional amputation-related and cardiovascular
procedures and cLOS was undertaken. To ﬁnd predictors
for the outcomes of amputation-related procedures,
nonamputation cardiovascular procedures, and cLOS,
independent variables were entered into Poisson regression
models for the outcome with the natural log of the person-
years under observation as the offset. The results were used
to determine the incidence rate ratio (IRR) for the inde-
pendent variable of interest compared with the reference
group. Variables were included in the multivariate models
at the P < .10 level. Age at index amputation was forced
into the model to account for unmeasured confounders.
The multivariate models were built through backward
selection. The level of signiﬁcance was set at a < .05.
The Cox proportional hazards method was used to ﬁnd
predictors of mortality. The proportional hazard assump-
tion for each independent variable was evaluated with the
Schonﬁeld residual method. All residuals had P > .05
suggesting the proportional hazard assumption was met
for all of the independent variables. A backward selection
method was used to build the ﬁnal model with the same
aforementioned parameters. All database linkages and
data analysis were performed with SAS 9.2 (SAS Institute,
Inc, Cary, NC).
RESULTS
There were 364 subjects who underwent index major
amputation between January 1995 and December 2000
(Table I). The study cohort included 210 men and 154
women with a mean age of 68.9 6 12.9 years. Most
patients (79.4%) were identiﬁed as white. The median
household income for zip code was $45,700. Black and
Hispanic subjects were signiﬁcantly more likely to reside
in zip codes with median household income in the lowest
Table I. Descriptive statistics and distribution of income by quartile
Variable Total
Income Q1 #$37,067
(N ¼ 103)
Income Q2-Q4 >$37,067
(N ¼ 261) P
Mean age at amputation, years 68.9 68.3 69.1 .411
Male gender 57.5% (n ¼ 210) 61.2% (n ¼ 63) 56.3% (n ¼ 147) .400
Race
White 79.4% (n ¼ 289) 65.0% (n ¼ 67) 85.0% (n ¼ 222) <.001
Black 10.4% (n ¼ 38) 18.4% (n ¼ 19) 7.3% (n ¼ 19) .002
Hispanic 3.3% (n ¼ 12) 7.8% (n ¼ 8) 1.5% (n ¼ 4) .003
Asian 0.3% (n ¼ 1) 0.0% (n ¼ 0) 0.4% (n ¼ 1) .530
Other 0.6% (n ¼ 2) 1.0% (n ¼ 1) 0.4% (n ¼ 1) .498
Unknown 6.0% (n ¼ 22) 7.8% (n ¼ 8) 5.4% (n ¼ 14) .388
Marital status
Married 47.5% (n ¼ 173) 36.9% (n ¼ 38) 51.7% (n ¼ 135) .011
Divorced/separated 9.6% (n ¼ 35) 12.6% (n ¼ 13) 8.4% (n ¼ 22) .224
Widowed 22.3% (n ¼ 81) 24.3% (n ¼ 25) 21.5% (n ¼ 56) .562
Single 16.2% (n ¼ 59) 25.2% (n ¼ 26) 12.6% (n ¼ 33) .004
Unknown 4.4% (n ¼ 16) 1.0% (n ¼ 1) 5.8% (n ¼ 15) .046
Payer
Medicare 70.9% (n ¼ 258) 67.0% (n ¼ 69) 72.4% (n ¼ 189) .307
Medicaid 5.2% (n ¼ 19) 7.8% (n ¼ 8) 4.2% (n ¼ 11) .172
Private 20.6% (n ¼ 75) 22.3% (n ¼ 23) 19.9% (n ¼ 52) .610
Self-pay 3.3% (n ¼ 12) 2.9% (n ¼ 3) 3.5% (n ¼ 9) .798
AHRQ comorbidities
CHF 23.9% (n ¼ 87) 25.2% (n ¼ 26) 23.4% (n ¼ 61) .707
DM, uncomplicated 26.9% (n ¼ 98) 34.0% (n ¼ 35) 24.1% (n ¼ 63) .058
DM, with complications 21.2% (n ¼ 77) 19.4% (n ¼ 20) 21.8% (n ¼ 57) .612
Renal failure 22.5% (n ¼ 82) 22.3% (n ¼ 23) 22.6% (n ¼ 59) .956
BKA 70.6% (n ¼ 257) 72.0% (n ¼ 188) 67.0% (n ¼ 69) .343
AHRQ, Agency for Healthcare Research and Quality; BKA, below-knee amputation; CHF, congestive heart failure; DM, diabetes mellitus; Q1, ﬁrst quartile;
Q2-Q4, second through fourth quartile.
JOURNAL OF VASCULAR SURGERY
786 Henry et al March 2013quartile. Although only 47.5% reported being married at
the time of the index procedure, married subjects were
more likely to have a higher median household income
(P ¼ .011). Most subjects were Medicare beneﬁciaries
(70.9%) or were privately insured (20.6%). Approximately
half of the subjects had diabetes. Most subjects (70.6%)
underwent below-knee amputation (BKA) as the index
procedure (Fig 1). Of those subjects, 78 had additional
amputations or conversions to more proximal amputations,
including 47 subjects who underwent ipsilateral conversion
to above-knee amputation (AKA) and 43 who underwent
contralateral amputations. AKA was the index procedure
for 29.4% of the cohort (Fig 2); 12 of these patients also
had contralateral amputations. There were 60 conversions
from BKA to AKA performed. Of conversions, 27 were
completed <1 month after the initial BKA. An additional
20 conversions were performed between 1 to 6 months
after the initial BKA, and the remaining 13 were completed
$6 months after the initial BKA.
During a mean follow-up of 3.25 years, patients had
a mean cLOS of 71.2 days per person-year (median,
17.6; interquartile range [IQR], 4.9-69.7), 19.5 readmis-
sions per person-year (median, 2.1; IQR, 0.1-8.2), 0.57
additional amputation-related procedures per person-year
(median, 0; IQR, 0-0.12), and 0.31 cardiovascular proce-
dures per person-year (median, 0; IQR, 0-0). Of readmis-
sions #30 days after amputation, 52% were related to the
amputation, and 20.5% were related to cardiovascular orcerebrovascular disease (Table II). Overall mortality during
follow-up was 86.9%, with 37 patients (10.2%) dying
within 30 days. Median survival was 2.14 years.
Review of the medical records of patients who died
within 30 days of the amputation showed that these patients
had more severe critical illnesses than patients who survived
>30 days. To focus on patients who survived the initial post-
operative period, we restricted further analysis of cLOS,
additional amputation-related and cardiovascular proce-
dures, and mortality to the 327 subjects who survived
>30 days. Several SES-related and disease-related factors
inﬂuenced cLOS (Table III). Younger age (IRR for
increasing age, 0.98; 95% conﬁdence interval [CI], 0.97-
0.99; P ¼ .0023), public insurance (IRR, 1.63; 95% CI,
1.17-2.27; P ¼ .0042), lack of insurance (IRR, 2.06; 95%
CI, 1.09-3.87; P ¼ .0254), congestive heart failure (IRR,
1.61; 95% CI, 1.12-2.29; P ¼ .0095), and renal failure
(IRR, 2.12; 95% CI, 1.55-2.90; P< .0001) were associated
with longer cLOS over the duration of follow-up. Index
amputation level did not have a signiﬁcant association with
increasing cLOS. Complicated diabetes (IRR, 1.90; 95%
CI, 1.09-3.32; P ¼ .0248), renal failure (IRR, 2.47; 95%
CI, 1.38-4.22; P ¼ .0023), and undergoing index BKA
(IRR, 2.43; 95% CI, 1.10-5.33; P ¼ .0276) increased
the number of additional amputation-related procedures.
Increasing numbers of cardiovascular procedures, including
procedures for coronary, cerebrovascular, aortic, and periph-
eral artery occlusive disease, were related to congestive heart
Fig 1. Index below-knee amputation (BKA): additional amputations. AKA, Above-knee amputation.
Fig 2. Index above-knee amputation (AKA): additional amputa-
tions. BKA, Below-knee amputation.
Table II. Admitting diagnosis for readmissions within
30 days of amputation
Admitting diagnosis N ¼ 73
Amputation and PAD related 38
Fever 3
Cardiovascular/stroke 15
Pulmonary 4
Gastrointestinal 9
Other 4
PAD, Peripheral artery disease.
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failure (IRR, 3.67; 95% CI, 2.31-5.83; P < .0001). Older
age at index amputation, comorbidities, and initial amputa-
tion level were risk factors for decreased survival. Increasing
age (hazard ratio [HR], 1.04; 95%CI, 1.02-1.05;P< .0001)
and the presence of congestive heart failure (HR, 2.26; 95%
CI, 1.68-3.04; P < .0001) or renal failure (HR, 2.60; 95%
CI, 1.90-3.54; P < .0001) had signiﬁcant inﬂuences on
decreased survival. Undergoing AKA as the index amputa-
tion was also associated with decreased survival (HR, 1.37;
95% CI, 1.05-1.78; P ¼ .0225).
SES factors were not signiﬁcantly related to the
outcomes in multivariate analysis. Analysis of colinearity
between SES factors revealed low numbers of black,
Hispanic, and unmarried patients in the higher income
groups (Table IV). Patients who were identiﬁed as white
were signiﬁcantly more likely to reside in zip codes with
higher median household income than black or Hispanic
patients. Similar differences in median household income
were also found between married patients and their single
counterparts. Most patients were Medicare beneﬁciaries,and there were no signiﬁcant differences in insurance status
between the two income groups.
DISCUSSION
Older age, renal failure, and diabetes with chronic
complications are risk factors associated with increased
long-term RU and decreased survival after major amputa-
tion. RU is high for amputees and increased RU, including
amputation-related procedures and interventions to treat
systemic atherosclerosis, persists beyond the perioperative
period. The primary ﬁnding in this study is that the initial
amputation is often the ﬁrst in a series of procedures
including stump revision and conversion of BKA to AKA.
Additionally, patients who undergo amputations are at
high risk of undergoing subsequent procedures to treat
systemic atherosclerosis. Results were similar across indices
of SES, including race, income, and marital status, suggest-
ing that higher SES may not be protective against poor
outcomes when limb salvage is no longer attainable and
that indices of lower SES are colinear.
Measures of RU in amputees include index length of
stay and cLOS, number of readmissions, and the need for
additional amputation-related and cardiovascular-related
procedures. This study examined outcomes over a 10-year
Table III. Multivariate results for outcome of
cumulative length of stay
Variable
Incidence
rate ratio 95% CI P
Age 0.984 0.973-0.994 .0023
Race
White Reference
Black 1.235 0.863-1.767 .2495
Hispanic 0.520 0.213-1.268 .1505
Asian 6.562 0.948-45.432 .0567
Other/unknown 0.395 0.045-3.460 .4012
Payer
Private Reference
Medicare/Medicaid 1.627 1.166-2.269 .0042
Self-pay 2.056 1.093-3.868 .0254
CHF 1.605 1.123-2.293 .0095
Renal failure 2.117 1.545-2.900 <.001
CHF, Congestive heart failure; CI, conﬁdence interval.
Table IV. Colinearity between socioeconomic status
indices
Variable
Income
Q1 #$37,067
(N ¼ 103)
Income
Q2-Q4 >$37,067
(N ¼ 261) P
Mean age at
amputation, years
68.3 69.1 .411
Male gender 61.2% (n ¼ 63) 56.3% (n ¼ 147) .400
Race
White 65.0% (n ¼ 67) 85.0% (n ¼ 222) <.001
Black 18.4% (n ¼ 19) 7.3% (n ¼ 19) .002
Hispanic 7.8% (n ¼ 8) 1.5% (n ¼ 4) .003
Asian 0.0% (n ¼ 0) 0.4% (n ¼ 1) .530
Other 1.0% (n ¼ 1) 0.4% (n ¼ 1) .498
Unknown 7.8% (n ¼ 8) 5.4% (n ¼ 14) .388
Marital status
Married 36.9% (n ¼ 38) 51.7% (n ¼ 135) .011
Divorced/
separated
12.6% (n ¼ 13) 8.4% (n ¼ 22) .224
Widowed 24.3% (n ¼ 25) 21.5% (n ¼ 56) .562
Single 25.2% (n ¼ 26) 12.6% (n ¼ 33) .004
Unknown 1.0% (n ¼ 1) 5.8% (n ¼ 15) .046
Payer
Medicare 67.0% (n ¼ 69) 72.4% (n ¼ 189) .307
Medicaid 7.8% (n ¼ 8) 4.2% (n ¼ 11) .172
Private 22.3% (n ¼ 23) 19.9% (n ¼ 52) .610
Self-pay 2.9% (n ¼ 3) 3.5% (n ¼ 9) .798
Q1, ﬁrst quartile; Q2-Q4, second through fourth quartile.
JOURNAL OF VASCULAR SURGERY
788 Henry et al March 2013period of follow-up; the mean follow-up was 3.25 years.
Previously, RU in amputees had not been studied beyond
2 years. Our ﬁndings are in agreement with a more recent
analysis of patients in the REACH study. In this study,
patients undergoing revascularization or amputation for
CLI were more likely to experience recurring hospitaliza-
tions and repeat revascularization and amputation-related
procedures. These subsequent procedures led to signiﬁ-
cantly higher overall 2-year costs in these subgroups
($10,430 for patients undergoing revascularization and
$11,693 for patients undergoing amputation compared
with $7000 for patients with claudication; P ¼ .007).
Patients who had undergone amputation before the study
had the highest rates of cardiovascular events over the
2-year study period, and patients with a history of claudica-
tion but no prior revascularization or amputation had the
lowest rates.1 A second study focusing on long-term
outcomes for amputees in Department of Veterans Affairs
hospitals also found that this patient population required
frequent readmissions. Among 4061 above-knee and
below-knee amputees, there were 10,827 readmissions to
Department of Veterans Affairs medical centers over a
median follow-up of 32.1 months. Most patients (2868;
70.6%) had at least one readmission.
Compared with patients undergoing revascularization
procedures, amputees in our study had a substantially
longer cLOS. In the PRoject of Ex-Vivo vein graft ENgi-
neering via Transfection III (PREVENT III) trial, patients
presenting with tissue loss had a cLOS of 27.7 inpatient
days over the year of observation.5 Similarly, the Bypass
versus Angioplasty in Severe Ischaemia of the Leg (BASIL)
trial investigators reported the cLOS for all inpatient
admissions over a 2-year period to be slightly >2 months.9
We found the mean cLOS to be >71 days per person-year.
RU in this population may surpass that of other popula-
tions with chronic disease. Using data from a large private
multipayer health insurance database, Vera-Llonch et al10
reported a yearly length of stay of 8.9 days in patients
receiving chemotherapy for metastatic lung cancer. Asecond study of women undergoing treatment for recur-
rent or refractory ovarian cancer found a median cLOS of
33 days over a 2-year follow-up period.11 Better under-
standing of the driving forces behind longer length of
stay in amputees may lead to optimized resource allocation
and improved patient outcomes.
The current literature has not correlated measures of
RU with patient-centered outcomes such as quality of
life, return to independent living status, or prosthetic use.
To determine if RU is appropriate, future research should
focus on associations between these measures and
outcomes related to functional status and quality of life.
Undergoing multiple amputation revisions may indicate
aggressive measures to treat CLI or chronic infection that
precede conversion to a more proximal amputation. Alter-
natively, the need for additional procedures could represent
increased severity of disease, inadequate restoration of
blood supply to remaining tissue, or suboptimal manage-
ment of comorbidities that contribute to poor wound
healing. This study is an important ﬁrst step in delineating
the types of resources used over the long term for amputees
that may inﬂuence quality of life and functional status.
Congestive heart failure and renal failure were major
factors contributing to decreased survival in this cohort.
These comorbidities are also associated with premature
mortality in patients without PAD and may have synergistic
effects on morbidity and mortality in patients with severe
CLI requiring major amputation.12-14 The negative impact
of these comorbidities on outcomes for amputees under-
scores the need for a multidisciplinary approach to care
that continues to focus on risk factor reduction and
JOURNAL OF VASCULAR SURGERY
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diabetes. Undergoing AKA during the index procedure
was related to decreased survival. However, this association
is likely not causal in this subgroup of patients who were
evaluated for limb salvage at tertiary centers but required
AKA. These patients may have been more likely to have
sepsis owing to ischemic gangrene, severe comorbidities,
or shortened life expectancy. Therefore, AKA may be
a marker for critical life-threatening illness rather than
a cause of death.
Lower SES was not signiﬁcantly associated with
increased RU or decreased survival. A previous study of
patients undergoing amputation at a large Midwestern
teaching hospital during the same time period as the
current study found that after adjusting for age, gender,
and diabetes prevalence, black and white patients had an
equal likelihood of primary amputation, but that black
patients were 2.5 times more likely to undergo repeat
amputation than white patients.15 Over a longer period
of follow-up, we did not ﬁnd that nonwhite race, low
income, or public insurance was associated with additional
amputation-related procedures. Although we found
evidence of colinearity between indices of lower SES, these
results suggest that late in the course of end-stage CLI,
lower SES is not detrimental to future outcomes, and
higher SES is not protective.
Our ﬁndings that many amputees undergo subsequent
amputation-related procedures and are readmitted for
inpatient care highlight the importance of addressing the
long-term needs of this patient population. Within the
U.S. health care system, vascular surgeons work closely
with primary care providers and specialists to manage risk
factors for worsening PAD. Vascular surgeons also collab-
orate with specialists in physical medicine and rehabilitation
to coordinate acute care rehabilitation, care after discharge,
and transition to inpatient rehabilitation facilities that
support multidisciplinary programs for amputees. Acute
care and postacute care rehabilitation contributes to early
prosthetic use and re-entrance into community life.16
Ambulation with a prosthesis, quality of life, and ability
to participate in rehabilitation all are increased by
a system-level focus on the care of amputees and manage-
ment of comorbidities.17 We hope this work serves to
increase the focus given to amputees both before and after
the index procedure.
There are several limitations to this study. First, we
used retrospective administrative and billing data, which
do not capture disease severity with granular detail.
Although we were able to deﬁne conversions from BKAs
to AKAs and determine laterality, the database did not
provide consistent and uniform documentation distin-
guishing amputation revisions for poor wound healing
from planned revisions after guillotine amputations. We
combined amputation revisions, conversions, and subse-
quent contralateral amputations into one outcome to
facilitate analysis of a cohort with a skewed distribution
of outcomes. Second, there is evidence for colinearity
between SES factors. For example, there were very fewblack and Hispanic patients with higher incomes and few
patients without insurance. The study was underpowered
to detect a difference between combinations of race and
income categories given the small numbers. Patients
without insurance represent a heterogeneous population,
and a larger study cohort with more self-pay patients would
be better suited to draw conclusions about this group.
Third, we were unable to assess baseline functional status.
Patients who are nonambulatory or are nursing home
residents at baseline would be at different risk for the
selected outcomes compared with community-dwelling
patients. Additionally, low baseline functional status may
have led to treatment bias toward amputation rather than
revascularization.
These limitations notwithstanding, our study has
several important strengths. By evaluating outcomes over
10 years, we have further deﬁned long-term RU in this
population. Although our analysis was conﬁned to two
tertiary care centers, we were able to collect data on
subsequent procedures and conversion to more proximal
amputations and distinguish procedural laterality. These
data are not typically available in cross-sectional, national,
and multi-institutional databases compiled for third-party
researchers. By restricting our sample to patients who
were likely to use our institutions as their primary health
care site, these data likely reﬂect most cardiovascular-
related and amputation-related procedures undertaken in
this group. To address colinearity between race and income,
we are conducting a prospective study in patients with CLI,
and we are collecting data on more speciﬁc aspects of
income, ﬁnancial and social support, race/ethnicity, and
functional status over time.
Like many chronic conditions, providing care across
the continuum of PAD is resource intensive and may
involve interventions at multiple stages of the disease
process from diagnosis to end-stage disease management.
Existing literature focuses on resources consumed during
attempts at limb salvage. Our current work contributes to
knowledge in this area by beginning to delineate the types
of interventions and resources used after amputation and
describing the factors that inﬂuence RU. We have demon-
strated that amputation level and the presence of cardiovas-
cular disease, diabetes, and renal failure are associated with
increased RU and decreased survival after amputation.
Further study of RU after amputation focusing on post-
discharge care, rehabilitation, and costs to facilitate re-
entry into the community for amputees is warranted.
CONCLUSIONS
Amputation is not the end of treatment for severe CLI.
The index amputation often heralds future amputation
revisions, conversion to more proximal amputations, and
contralateral procedures in addition to other cardiovascular
procedures. Comorbidities including congestive heart
failure, renal failure, and diabetes with chronic complica-
tions were associated with increased long-term RU and
decreased survival. The ﬁnding that SES was not signiﬁ-
cantly related to RU after amputation suggests that SES
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790 Henry et al March 2013disparities may be more modiﬁable during earlier stages of
care for CLI. Further investigations into factors that predict
amputation conversions (BKA to AKA) or contralateral
amputations may help to identify patients who would
beneﬁt from more aggressive management of comorbid
diseases earlier in the course of treatment for PAD.
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